Grof Tisza Istvan Korhaz Berettyoujfalu
Berettyoujfalu, Hungary
Hospital in Berettyóújfalu
Berettyóújfalu, Orbán Balázs tér 1, 4100
About Grof Tisza Istvan Korhaz Berettyoujfalu
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Amgen
1
Daiichi Sankyo, Inc.
1
Resverlogix Corp
1
Clinical Trials at Grof Tisza Istvan Korhaz Berettyoujfalu
During the past decade, Grof Tisza Istvan Korhaz Berettyoujfalu conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
2015-11-01
2021-06-21
Completed
2,425
Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
2017-01-24
2018-10-09
Completed
607
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Grof Tisza Istvan Korhaz Berettyoujfalu"
#1 collaborator was "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Grof Tisza Istvan Korhaz Berettyoujfalu
According to Clinical.Site data, the most researched conditions in "Grof Tisza Istvan Korhaz Berettyoujfalu" are
"Cardiovascular Disease" (2 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Grof Tisza Istvan Korhaz Berettyoujfalu" in a lesser frequency.
Clinical Trials Intervention Types at Grof Tisza Istvan Korhaz Berettyoujfalu
Most popular intervention types in "Grof Tisza Istvan Korhaz Berettyoujfalu" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Apabetalone" (1 trials), "Atorvastatin" (1 trials) and "Edoxaban" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Grof Tisza Istvan Korhaz Berettyoujfalu
The vast majority of trials in "Grof Tisza Istvan Korhaz Berettyoujfalu" are
5 trials for "All" genders.
Clinical Trials Status at Grof Tisza Istvan Korhaz Berettyoujfalu
Currently, there are NaN active trials in "Grof Tisza Istvan Korhaz Berettyoujfalu".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Grof Tisza Istvan Korhaz Berettyoujfalu,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Grof Tisza Istvan Korhaz Berettyoujfalu, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".